Treatment of congenital and acquired hemophilia patients by extracorporeal removal of antibodies to coagulation factors: A review of US clinical studies 1987–1990
- 30 April 1992
- journal article
- case report
- Published by Elsevier in Transfusion Science
- Vol. 13 (2) , 233-253
- https://doi.org/10.1016/0955-3886(92)90176-h
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- REMOVAL OF LYMPHOCYTOTOXIC ANTIBODIES BY PRETRANSPLANT IMMUNOADSORPTION THERAPY IN HIGHLY SENSITIZED RENAL TRANSPLANT RECIPIENTSTransplantation, 1991
- Therapeutic protein A immunoadsorption. A reviewTransfusion Science, 1990
- Extracorporeal Removal of Anti-HLA Antibodies in Transplant CandidatesAmerican Journal of Kidney Diseases, 1990
- REMOVAL OF ANTI-HLA ANTIBODIES BY EXTRACORPOREAL IMMUNOADSORPTION TO ENABLE RENAL TRANSPLANTATIONThe Lancet, 1989
- TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS BY EXTRACORPOREAL IMMUNOADSORPTIONThe Lancet, 1988
- Induction of Immune Tolerance in Patients with Hemophilia and Antibodies to Factor VIII by Combined Treatment with Intravenous IgG, Cyclophosphamide, and Factor VIIINew England Journal of Medicine, 1988
- GOODPASTURE'S SYNDROME TREATED WITH STAPHYLOCOCCAL PROTEIN A IMMUNOADSORPTIONThe Lancet, 1985
- Suppression of Secondary Antibody Response by Intravenous Immunoglobulin in a Patient with Haemophilia B and AntibodiesScandinavian Journal of Haematology, 1983
- A procedure for removing high titer antibodies by extracorporeal protein-A-sepharose adsorption in hemophilia: substitution therapy and surgery in a patient with hemophilia B and antibodiesBlood, 1981
- Antibodies to factor VIII. V. Patterns of immune response to factor VIII in hemophilia ABlood, 1976